Silver nanoparticles inhibit replication of respiratory syncytial virus

Journal of Biomedical Nanotechnology

Volumn 4, Issue 2, 2008, Pages 149-158

  Sun, Lova ^a   Singh, Ankur K ^a   Vig, Komal ^a   Pillai, Shreekumar R ^a   Singh, Shree R ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

Hep 2 cells; Poly(N vinyl 2 pyrrolidone); Respiratory Syncytial Virus; Silver nanoparticles; Viral infection inhibition

Indexed keywords

ANTIINFECTIVE AGENT; BOVINE SERUM ALBUMIN; HYBRID PROTEIN; METAL NANOPARTICLE; POLYLACTIC ACID; POVIDONE; SILVER;

ARTICLE; BIOASSAY; CELL CULTURE; CLINICAL EFFECTIVENESS; CONCENTRATION PROCESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG SYNTHESIS; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 58149083893     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. K. Vaughan, G. H. Rhodes, and L. J. Gershwin, DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. Vaccine 23, 2928 (2005).
2. R. A. Dudas and R. A. Karron, Respiratory syncytial virus vaccines. Clin. Micro. Rev. 11, 430 (1998).
3. G. P. Bembridge, N. Rodriguez, R. Garcia-Beato, C. Nicolson, J. A. Melero, and G. Taylor, DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J. Gen. Virol. 81, 2519 (2000).
4. M. Ushio, I. Yui, N. Yoshida, M. Fujino, T. Yonekawa, Y. Ota, T. Notomi, and T. Nakayama, Detection of respiratory syncytial virus genome by subgroups-A, B specific reverse transcription loop-mediated isothermal amplification (RT-LAMP). J. Med. Virol. 77, 121 (2005).
5. X. Li, S. Sambhara, C. X. Li, M. Ewasyshyn, M. Parrington, J. Caterini, O. James, G. Cates, R.-P. Du, and M. Klein, Protection against respiratory syncytial virus infection by DNA immunization. J. Exp. Med. 188, 681 (1998).
6. A. R. Falsey and E. E. Walsh, Respiratory syncytial virus infections in adults. Clin. Micro. Rev. 13, 371 (2000).
7. M. K. Iwane, K. M. Edwards, P. G. Szilagyi, F. J. Walker, M. R. Griffin, G. A. Weinberg, C. Coulen, K. A. Poehling, L. P. Shone, S. Balter, C. B. Hall, D. D. Erdman, K. Wooten, and B. Schwartz, Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113, 1758 (2004).
8. S. C. Brock, J. R. Goldenring, and J. E. J. Crowe, Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc. Nat. Am. Sci. 100, 15143 ( 2003).
9. G. P. Bembridge, N. Rodriguez, R. Garcia-Beato, C. Nicolson, J. A. Melero, and G. Taylor, Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein. Vaccine 19, 1038 (2001).
10. B. Z. Katz, J. Lo, and M. Sortentino, Costs of respiratory syncytial virus infection at a tertiary-care children's hospital. Pharmacol. Ther. 28, 343 (2003).
11. E. E. Walsh, Humoral, mucosal and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine. J. Infect. Dis. 170, 345 (1994).
12. X. Martinez, X. Li, J. Kovarik, M. Klein, P. H. Lambert, and C. A. Siegrist, Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice. Eur. J. Immunol. 29, 3390 (1999).
13. E. K. Park, B. Y. Soh, Y. S. Jang, J. H. Park, and G. H. Chung, Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus. Mol. Cells 12, 50 (2001).
14. R. W. Sidwell and D. L. Barnard, Respiratory syncytial virus infections: Recent prospects for control. Antiviral Res. 71, 379 (2006).
15. D. Hacking and J. Hull, Respiratory syncytial virus-viral biology and the host response. J. Infect. 45, 18 (2002).
16. P. W. Tebbey, C. A. Scheuer, J. A. Peek, D. Zhu, N. A. LaPierre, B. A. Green, E. D. Phillips, A. R. Ibraghimov, J. H. Eldridge, and G. E. Hancock, Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H. Vaccine 18, 2723 (2000).
17. X. Li, S. Sambhara, C. X. Li, L. Ettorre, I. Switzer, G. Cates, O. James, M. Parrington, R. Oomen, R.-P. Du, and M. Klein, Plasmid DNA encoding respiratory syncytial virus G protein is a promising vaccine candidate. Virology 269, 54 (2000).
18. L. Pietro, D. R. Silva, M. C. Alberto-Rincon, and E. A. Duek, The influence of triethylcitrate on the biological properties of poly(L-lactic-co-glycolic acid) membranes. J. Mater. Sci. Mater. Med. 17, 849 (2006).
19. F. A. Barber and W. D. Dockery, Long-term absorption of poly-L-lactic acid interference screws. Arthroscopy 22, 820 (2006).
20. J. L. Elechiguerra, J. L. Burt, J. R. Morones, A. Camacho-Bragado, X. Gao, H. H. Lara, and M. J. Yacaman, Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3, 6 (2005).
21. Z. Wang, J. Lee, A. R. Cossins, and M. Brust, Microarray-based detection of protein binding and functionality by gold nanoparticle probes. Anal. Chem. 77, 5779 (2005).
22. J. L. Burt, C. Gutierrez-Wing, M. Miki-Yoshida, and M. J. Yacaman, Noble-metal nanoparticles directly conjugated to globular proteins. Langmuir 20, 11778 (2004).
23. R. Levy, N. T. K. Thanh, R. C. Doty, I. Hussain, R. J. Nichols, D. J. Schiffrin, M. Brust, and D. G. Fernig, Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J. Am. Chem. Soc. 126, 10076 (2004).
24. F. Furo, K. S. Morley, B. Wong, B. L. Sharp, P. L. Arnold, S. M. Howdle, R. Bayston, P. D. Brown, P. D. Winship, and H. J. Reid, Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection. J. Antimicrob. Chemother. 54, 1019 ( 2004).
25. S. R. Singh, V. A. Dennis, C. L. Carter, S. R. Pillai, A. Jefferson, S. V. Sahi, and E. G. Moore, Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model. Vaccine 25, 6211 (2007).
26. R. A. Lamb and D. Kolakofsky, Paramyxoviridae: The viruses and their replication, Fundamental Virology, 3rd edn., edited by P. M. Howley, Lippincott-Raven Publishers, Philadelphia (1996), p. 577.
27. P. Tillmann, J. Mitchell, and J. Abanulo, Stability of silver nanoparticles in aqueous and organic media. NNIN REU Research Accomplishments 140 (2004).
28. S. M. Hussain, K. L. Hess, J. M. Gearhart, K. T. Geiss, and J. J. Schlager, In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 19, 975 (2005).
29. L. Braydich-Stolle, L. Hussain, J. J. Schlager, and M. C. Hofmann, In Vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 88, 412 (2005).